Dr Jordan Hansford

Dr Jordan Hansford

Details

Role Honorary Fellow
Research area Stem Cell Medicine

Top Publications

  • Valvi, S, Manoharan, N, Mateos, MK, Hassall, TE, Ziegler, DS, McCowage, GB, Dun, MD, Eisenstat, DD, Gottardo, NG, Hansford, JR. Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement.. Med J Aust 2024
    view publication
  • Kilburn, LB, Khuong-Quang, D-A, Hansford, JR, Landi, D, van der Lugt, J, Leary, SES, Driever, PH, Bailey, S, Perreault, S, McCowage, G, et al. Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.. Nat Med 30(5) : 1500 2024
    view publication
  • Ercan, AB, Aronson, M, Fernandez, NR, Chang, Y, Levine, A, Liu, ZA, Negm, L, Edwards, M, Bianchi, V, Stengs, L, et al. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.. Lancet Oncol 25(5) : 668 -682 2024
    view publication
  • Hansford, JR, Das, A, McGee, RB, Nakano, Y, Brzezinski, J, Scollon, SR, Rednam, SP, Schienda, J, Michaeli, O, Kim, SY, et al. Update on cancer predisposition syndromes and surveillance guidelines for childhood brain tumors.. Clin Cancer Res 2024
    view publication
  • Duchatel, RJ, Jackson, ER, Parackal, SG, Kiltschewskij, D, Findlay, IJ, Mannan, A, Staudt, DE, Thomas, BC, Germon, ZP, Laternser, S, et al. PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.. J Clin Invest 134(6) : 2024
    view publication

Page 1 of 37